Clinical Trial Update: Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine [Phase 1]

View source ↗

Summary

Phase 1 trial update reporting the disposition of eslicarbazepine acetate and its metabolites S-licarbazepine and R-licarbazepine, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• R-licarbazepine (R-licarbazepine)
• S-licarbazepine (S-licarbazepine)
• eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-03